Medication info

Baiete Tablet 10/20 Milligrams

Prescription medicationApproval withdrawn
Ingredient · strength
Ezetimibe›Strength being verifiedSimvastatin›Strength being verified
Manufacturer / importer
Poongrim Pharmaceutical Co., Ltd.
Appearance
White to off-white, biconvex, rectangular tablets
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Approval withdrawn

MFDS item code 201901140 · Approved 2019.02.22

This product's status changed to Approval withdrawn on 2023.08.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who uses it
Adults
Adult dosage
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dosage of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range for this drug is 10/10mg to 10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10mg once daily. After starting this drug or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have been taking this drug at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This drug is used as an adjunct to other lipid-lowering therapy (e.g., LDL apheresis) or when other lipid-lowering therapies are not useful. Administration to patients with hepatic impairment No dosage adjustment is necessary for patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 4. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). Patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡ should receive 10/20mg of this drug once daily in the evening. When administering higher doses of this drug to these patients, use caution and monitor them closely (see Precautions for Use, 4. General Precautions). Administration to elderly patients No dosage adjustment is necessary in elderly patients. Concomitant administration with other drugs (See Precautions for Use, 5. Interactions.) This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Ingredients

Manufacturer
Poongrim Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • atherosclerotic vascular disease
  • dyslipidemia
View approved original text

This medication helps lower cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia, and raises good cholesterol (HDL). It also lowers total cholesterol and LDL cholesterol levels in patients with homozygous familial hypercholesterolemia when used in conjunction with other treatments or alone. This drug is prescribed in conjunction with dietary changes when simple dietary modification is insufficient. Before treatment, secondary causes such as diabetes or hypothyroidism should be checked, and lipid levels should be regularly monitored through blood tests. Lipid levels should also be checked during acute cardiovascular events to inform treatment plans. Therefore, this medication is used effectively to improve hypercholesterolemia and its associated cardiovascular disease risk.

Dosage and Administration

Adult dosage

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dosage of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range for this drug is 10/10mg to 10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10mg once daily. After starting this drug or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have been taking this drug at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This drug is used as an adjunct to other lipid-lowering therapy (e.g., LDL apheresis) or when other lipid-lowering therapies are not useful. Administration to patients with hepatic impairment No dosage adjustment is necessary for patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 4. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). Patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡ should receive 10/20mg of this drug once daily in the evening. When administering higher doses of this drug to these patients, use caution and monitor them closely (see Precautions for Use, 4. General Precautions). Administration to elderly patients No dosage adjustment is necessary in elderly patients. Concomitant administration with other drugs (See Precautions for Use, 5. Interactions.) This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Precautions

This medication can cause muscle-related side effects such as myopathy or rhabdomyolysis, so if symptoms of muscle pain or weakness occur, the doctor should be informed immediately. This medication should not be used in individuals with allergies to certain components, active liver disease, or in women who are pregnant or breastfeeding. Patients with impaired liver function should consult a doctor before taking this medication, and treatment should be discontinued immediately if symptoms of liver dysfunction occur. This medication has a high potential for interactions with other medicines, so patients must inform their doctor or pharmacist of any other medications being taken. Particularly, concurrent use with strong CYP3A4 inhibitors, gemfibrozil, cyclosporine, danazol, and other medications may increase the risk of muscle-related side effects. During the use of this medication, regular blood tests to check liver function and muscle enzyme levels are recommended. Women planning to become pregnant or who may be pregnant should consult a doctor before taking this medication, and it should be discontinued immediately if pregnancy is confirmed. The safety and efficacy of this medication in children and adolescents have not been sufficiently proven, so caution is advised for use. Elderly patients may respond more sensitively to this medication, so caution is needed when taking it. In case of overdose, there are no specific antidotes, so immediate medical attention should be sought for appropriate treatment. Additionally, during the use of this medication, unexplained muscle pain or weakness, fatigue, indigestion, headache, and other symptoms may occur, and patients should consult a doctor if these symptoms arise.

Side effects

  • myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 88 more
  • nausea
  • abdominal pain
  • constipation
  • dyspepsia
  • flatulence
  • pruritus
  • rash
  • arthralgia
  • low back pain
  • weakness
  • cataract
  • pharyngitis
  • sinusitis
  • cough
  • angioedema
  • rash
  • pancreatitis
  • cholelithiasis
  • cholecystitis
  • eczema
  • decreased libido
  • sexual dysfunction
  • alopecia
  • skin changes
  • drug-induced lichenoid eruption
  • gynecomastia
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated gamma-GT
  • elevated bilirubin
  • thyroid dysfunction
  • sensory disturbances
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • depression
  • tremors
  • dizziness
  • specific cranial nerve dysfunction
  • interstitial lung disease
  • hypersensitivity reactions
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • hepatitis
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic failure
  • liver cancer
  • loss of appetite
  • vomiting
  • chest pain
  • chest discomfort
  • sensory loss
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • increased serum creatine phosphokinase
  • weight loss
  • increased HbA1c
  • elevated fasting blood glucose levels

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the medication's efficacy and prevent deterioration.

Appearance and packaging

Appearance

White to off-white, biconvex, rectangular tablets

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.